Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
- PMID: 12730697
- DOI: 10.1038/ng1161
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Abstract
Autosomal dominant hypercholesterolemia (ADH; OMIM144400), a risk factor for coronary heart disease, is characterized by an increase in low-density lipoprotein cholesterol levels that is associated with mutations in the genes LDLR (encoding low-density lipoprotein receptor) or APOB (encoding apolipoprotein B). We mapped a third locus associated with ADH, HCHOLA3 at 1p32, and now report two mutations in the gene PCSK9 (encoding proprotein convertase subtilisin/kexin type 9) that cause ADH. PCSK9 encodes NARC-1 (neural apoptosis regulated convertase), a newly identified human subtilase that is highly expressed in the liver and contributes to cholesterol homeostasis.
Comment in
-
One-shot, one cure with genome editing for dyslipidemia.Circ Cardiovasc Genet. 2014 Dec;7(6):967-8. doi: 10.1161/CIRCGENETICS.114.000958. Circ Cardiovasc Genet. 2014. PMID: 25516627 No abstract available.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
